Ignite Creation Date:
2024-05-06 @ 3:01 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04494425
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2020-07-20
Brief Title:
Study of Trastuzumab Deruxtecan T-DXd vs Investigators Choice Chemotherapy in HER2-low Hormone Receptor Positive Metastatic Breast Cancer
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-06-19
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-20
First Submit QC Date:
July 28 2020
Study First Post Date:
2020-07-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-16
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL